NightFood – Flawless Execution

S" itemprop="articleBody">

Sean Folkson, founder and CEO of NightFood, has executed on his vision and deliverables timeline flawlessly – a clear sign of a great CEO.

We first started covering $NGTF in early November 2017 when the stock was trading at $.08 with an average daily volume of just 18,000. Since then, the shares have had a nice run and we expect much more on the upside.  They hit a high of $.69 Jan 18, 2018 and have since consolidated nicely in the $.50 range. The 30 day average daily volume has increased to a very healthy 750,000 from just 18,000.

Some recent remarkable NightFood highlights:

March, 01 2018: NightFood Investor Conference Call: Thursday, March 01 2018 at 4:30 EST. 

“Innovative snack brand development company NightFood Holdings, Inc. (OTC: NGTF), is pleased to announce that the Company has scheduled an investor conference call at 4:30 PM eastern standard time on Thursday, Mar 1st, 2018.

“It’s been a very eventful and very successful three months for both NightFood and MJ Munchies,” commented Company CEO Sean Folkson.  “We respect the importance of open communication, and enjoy keeping investors up to date on Company developments through these ongoing quarterly calls.”

On the call, NightFood Founder and CEO, Sean Folkson, will address:

  • The MJ Munchies and Half-Baked™ initiatives, including the Company acquisition of
  • NightFood’s addition of Greg Getner as head of digital growth, and Dr. Michael Breus, The Sleep Doctor™, to the NightFood brand team
  • The product development pipeline for both MJ Munchies and NightFood”



Feb, 20 2018:  The Sleep Doctor, world renown Dr. Michael Breus Joins NighFood

“Breus, known to millions as The Sleep Doctor™,  Breus is the Nation’s most trusted authority on sleep.  He regularly appears in the national media to educate and inform consumers so they can sleep better and lead happier, healthier, more productive lives. 

In addition to over 40 appearances on The Dr. Oz Show, Dr. Breus has appeared on The View, Oprah, Anderson Cooper, Rachel Ray, Fox and Friends, The Doctors, The CBS Early Show, Kelly and Michael, The Today Show, and more.  He has been the resident sleep expert on WebMD for over 15 years, and is a regular contributor to The Huffington Post and Psychology Today. “


Feb, 14 2018: NightFood Acquires for Cannabis-Related Snack and Edibles Lines

“Snack brand development company NightFood Holdings, Inc. (OTC: NGTF) announced today that MJ Munchies, an NGTF wholly owned subsidiary, has completed acquisition of 

The Company intends to use the domain for online sales and marketing of its marijuana-related snack and edible lines, to be marketed under the trademarked brand name, Half-Baked. 

It was recently announced that the Company had completed its application with the United States Patent and Trademark office for the brand name “Half-Baked” through their corporate intellectual property law firm, Pinnacle IP Strategies.”


Great to see a grounded CEO with serious focus and execution – Hat tip Sean! 🙂

Based on recent corporate developments we see a $1.50 share price in Q2, 2018. 

Anna MORERA LERALTA, Medical Doctor 2018

@MedTechpreneur   /   @AnnaDocpreneur

P.S. The more we learn about Yippy, Inc and spend time with founder and CEO Richard Granville the more we see clearly the absolutely massive opportunity for Yippy to become a dominant player in the new Internet 2. Search is changing and Yippy will be a very big player in the space. Get long! $YIPI 

Recent Posts

No Comments Yet

Leave a Reply

Latest Posts
  • An Ethical Champion Brings Reminiscence Therapy (RT) into the Digital Age

      For decades, scientists have searched for a cure or t…

  • Dthera Sciences Hits IBR Radar – Golden Opportunity

      Anytime I stumble upon a biotech company that uses di…

  • Exciting Investment Opportunities in New Digital Search Businesses

      Google’s Impressive History If you could scan your ow…

Internet Bull Report

Thank you for reading

Internet Bull Report is a financial newsletter that uncovers remarkable equities, primarily in the High Tech and Biotech sectors globally.


Subscribe to the IBR blog

Keep up to date with our latest news and recommendations by getting them straight to your inbox!

We will never spam you or give your email address to a third party.